Relmada Therapeutics Inc (RLMD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Relmada Therapeutics Inc  (NASDAQ: RLMD)


Relmada Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Relmada Therapeutics Inc's ROI in the second quarter of 2026?
Relmada Therapeutics Inc recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -3.23%.

Within the Healthcare sector 208 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3108, from total ROI ranking in the first quarter of 2026 at 3462.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 249.14 % 71.79 % -36.07 % -60.23 % -58.52 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 209 222 88 16 22
Return On Investment (TTM) -3.23 % -10.29 % -10.73 % -209.14 % -196.89 %
RLMD's Overall Ranking # 3108 # 3462 # 0 # 4031 #
Seq. Investment Change TTM 53.54 % 115.73 % 32.84 % -20.66 % -24.45 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -4 -9 -4 -64 -75

RLMD Company Profile >> Back to RLMD Roi Comparisons >> See Annual RLMD Return On Investment



Return On Investment RLMD's Ranking
Within: No.
Industry # 71
Sector # 209
Overall # 3108

Return On Investment Statistics
High Average Low
253.78 %
-12062.6 %
-478614.07 %
(Sep 30 2015)   (Jun 30 2018)







Financial Statements
Relmada Therapeutics Inc's II. Quarter Investments $ 209 Millions RLMD's Balance sheet
Relmada Therapeutics Inc's II. Quarter Income $ -13 Millions Quarterly RLMD's Income Statement
RLMD's Income by Division See RLMD's Income by Division


RLMD Annual Return On Investment (Sep 30 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 10 36 85 140 208
Y / Y Investment Growth -72.73 % -58.38 % -39.22 % -32.57 % 97.25 %
Net Income in Millions -10 -80 0 -157 -126
Y / Y Net Income Growth - - - - -
Annual Return On Investment -104.18 % -225.13 % 0 % -111.83 % -60.38 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RLMD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RLMD's Competitors
Subscribers only: Roi for Relmada Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for RLMD's Customers

Other Ratios
RLMD's Roa RLMD's Inventory Turnover Ratio RLMD's Growth Rates RLMD's Dividend Statistics
RLMD's Profitability Ratios RLMD's Asset Turnover Ratio RLMD's Dividend Growth
RLMD's Roe RLMD's Valuation Ratios RLMD's Financial Strength Ratios RLMD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:27:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.